USE OF PIPAMPERONE AND A D2-RECEPTOR ANTAGONIST OR A SEROTONIN/DOPAMIN ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDERS

• 1. 一种以5－羟色胺3受体拮抗剂和H₂受体拮抗剂为活性成分的药用组合物及其制药用途 [P] . 中国专利： CN100423779C . 2008.10.08
• 2. 一种以5－羟色胺3受体拮抗剂和H₂受体拮抗剂为活性成分的药用组合物及其用途 [P] . 中国专利： CN1927398A . 2007-03-14
• 3. USE OF PIPAMPERONE AND A D2-RECEPTOR ANTAGONIST OR A SEROTONIN/DOPAMIN ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDERS [P] . RS51331B . 2011-02-28

  机译： 使用皮潘酮和D2-受体拮抗剂或5-羟色胺/多巴胺拮抗剂治疗精神分裂症

• 4. USE OF PIPAMPERONE AND A D2-RECEPTOR ANTAGONIST OR A SEROTONIN/DOPAMIN ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDERS [P] . PT1708790E . 2010-07-09

  机译： 使用皮潘酮和D2-受体拮抗剂或5-羟色胺/多巴胺拮抗剂治疗精神分裂症

• 5. USE OF PIPAMPERONE AND A D2-RECEPTOR ANTAGONIST OR A SEROTONIN/DOPAMIN ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDERS [P] . PL1708790T3 . 2010-10-29

  机译： 使用皮潘酮和D2-受体拮抗剂或5-羟色胺/多巴胺拮抗剂治疗精神分裂症

• 1. CLINICAL COMPARISON OF THE SELECTIVE SEROTONIN3 ANTAGONISTS RAMOSETRON AND GRANISETRON IN TREATING ACUTE CHEMOTHERAPY-INDUCED EMESIS, NAUSEA AND ANOREXIA [J] . 冯奉仪, 张频, 何友兼, 中国医学科学杂志（英文版） . 2002,第003期
• 2. CLINICAL COMPARISON OF THE SELECTIVE SEROTONIN3 ANTAGONISTS RAMOSETRON AND GRANISETRON IN TREATING ACUTE CHEMOTHERAPY—INDUCED EMESIS,NAUSEA AND ANOREXIA [J] . 冯奉仪, 何友兼, 等 中国医学科学杂志：英文版 . 2002,第003期
• 3. Therapeutic potential of AMPA receptor antagonist perampanel against cerebral ischemia: beyond epileptic disorder [J] . Satoshi Suda, Kazumi Kimura 中国神经再生研究（英文版） . 2019,第009期
• 4. Extended Radioligand Binding Profile of Iloperidone: A Broad Spectrum Dopamine/Serotonin/Norepinephrine Receptor Antagonist for the Management of Psychotic Disorders [J] . Hans Otto Kalkman, Natarajan Subramanian, Daniel Hoyer Neuropsychopharmacology . 2001,第6期
• 5. A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [J] . Papakostas GI, Fava M European psychiatry: the journal of the Association of European Psychiatrists . 2007,第7期
• 6. Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: a potential treatment for psychotic disorders. [J] . Ito S, Hirata Y, Nagatomi Y Bioorganic and Medicinal Chemistry Letters . 2009,第18期
• 7. The Serotonin 5-HT2A Receptor Antagonist Ritanserin Induces Apoptosis in Human Colorectal Cancer and Acts in Synergy with Curcumin [C] . Ataee R., Oufkir T., Ataee A., European Congress of Pharmacology . 2012
• 8. PHOSPHOINOSITIDE HYDROLYSIS AS AN EFFECTOR SYSTEM OF CENTRAL SEROTONIN RECEPTORS (CHOROID PLEXUS, CEREBROSPINAL FLUID, CEREBRAL CORTEX, PHOSPHATIDYLINOSITOL HYDROLYSIS, SEROTONIN ANTAGONISTS). [D] . CONN, P. JEFFREY. 1986
• 9. Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder [O] . Craig A. Stockmeier, Eimear Howley, Xiaochun Shi, -1
• 10. Penggunaan serotonin dalam formulasi hormon pregnant mare serum gonadotropin dan antidopamin untuk menginduksi perkembangan gonad ikan ringau, Datnioides microlepis Bleeker, 1854 Serotonin application in pregnant mare serum gonadotropin hormone and dopamin antagonist formulation to induce gonadal development of Indonesian tigerfish (Datnioides microlepis Bleeker, 1854) [O] . NFN Bastiar, Agus Oman Sudrajat, Melta Rini Fahmi 2017

• 1. Long-Term, Open-Label, Safety Study of Edivoxetine as Adjunctive Treatment for Adult Patients with Major Depressive Disorder Who Were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment in Japan [J] . Emel Serap Monkul ,Mark Bangs ,Keita Asato . 精神病学期刊（英文） . 2015,第2期
• 2. Anti-post-traumatic stress disorder effect of dopamine D3 receptor antagonist [J] . SONG Da-ke ,GUO Liang-kun ,LU Guan-yi . 中国药理学与毒理学杂志 . 2018,第9期
• 3. 5羟色胺2C受体拮抗剂与反向激动剂逆转社会隔离小鼠异常攻击行为及其5羟色胺2C受体RNA编辑机制 [C] . 薛莹 ,余伟志 ,徐红 . 第十九次全国行为医学学术会议 . 2017
• 4. 新型抗精神分裂症多巴胺D3受体拮抗剂Y-QA14与Y-QA31的合成工艺优化 [A] . 王卫娜 . 2013